ℹ️
🇬🇧
Search
Search for publications relevant for "risankizumab"
risankizumab
Publication
Class
Person
Publication
Programmes
Export current view
publication
Long-term safety of risankizumab
2020 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Risankizumab in first-line treatment of psoriasis
2022 |
Faculty of Medicine in Pilsen
publication
A case of psoriasis treated with risankizumab at the time of the COVID-19 epidemic
2020 |
Faculty of Medicine in Hradec Králové
publication
New treatment options for psoriasis based on new findings in the pathogenesis of psoriasis - risankizumab
2020 |
Faculty of Medicine in Pilsen
publication
Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trial
2020 |
Faculty of Medicine in Pilsen
publication
Risankizumab in treatment of psoriatic arthritis
2023 |
First Faculty of Medicine
publication
Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal
2019 |
Faculty of Medicine in Pilsen
publication
Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (Clinical trial IMMerge)
2020 |
Faculty of Medicine in Pilsen
publication
Risankizumab
2019 |
Third Faculty of Medicine
publication
Coexistence of palmoplantar pustulosis and ichthyosis vulgaris treated by risankizumab
2021 |
Third Faculty of Medicine
publication
Risankizumab v léčbě psoriatické artritidy
2023 |
First Faculty of Medicine
publication
Acrodermatitis continua Hallopeau successfully treated by risankizumab
2021 |
Third Faculty of Medicine
publication
Successful treatment of refractory extensive pityriasis rubra pilaris with risankizumab
2021 |
Faculty of Medicine in Pilsen
publication
Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic
2021 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
publication
Successful treatment of psoriasis with risankizumab in an HIV positive patient with sexually transmitted infection comorbidities
2022 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Úspěšná léčba psoriázy risankizumabem u HIV pozitivního pacienta
2022 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Nová biologická léčba psoriázy: risankizumab - první klinické zkušenosti
2020 |
Third Faculty of Medicine
publication
Léčba risankizumabem u dvou pacientů s těžkou psoriázou po switchi z jiné biologické terapie
2021 |
Third Faculty of Medicine
publication
Zkušenosti s risankizumabem v léčbě středně těžké až těžké psoriázy v běžné klinické praxi
2021 |
Third Faculty of Medicine
publication
Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti-tumour necrosis factor alpha
2021 |
Third Faculty of Medicine
publication
1 Nehtová psoriáza léčená risankizumabem
2021 |
Third Faculty of Medicine
publication
9 Úspěšná léčba risankizumabem u pacientky s hidradenitis suppurativa a s roztroušenou sklerózou
2021 |
Third Faculty of Medicine
publication
Current Approach to Modern Treatment of Psoriasis - Updated Guidelines of ČDS JEP for Targeted Treatment of Severe Chronic Psoriasis
2019 |
Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine
publication
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study
2021 |
Third Faculty of Medicine
publication
Drug Survival of Interleukin (IL)-17 and IL-23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi-country, Multicentric Cohort Study
2022 |
Third Faculty of Medicine